Journals / Turkish Thoracic Journal / 2018 / Cilt: 19 - Sayı: 1

Association between the Serum Metabolic Profile and Lung Function in Chronic Obstructive Pulmonary Disease

Pages
13–18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We found an inverse correlation betweentriglyceride and functional residual capacity (p=-0.21, p=0.05) and a positive association between serum cholesterol and overall airwayresistance (R5) (p=0.24, p=0.04) and central airway resistance (R20) (p=0.32, p=0.004).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: Although dietary patterns are known to modulate disease severity in patients with chronic obstructive pulmonary disease (COPD),the relationship between the circulating lipid profile and lung function in COPD has not been studied extensively.MATERIAL AND METHODS: There were 43 COPD patients with a history of smoking and 39 patients with a history of biomass fuel exposurerecruited in this study, along with 43 age-matched healthy controls.
📊
Key Findings & Data:The association between the metabolic profile and lung function was assessed using the Spearman’srank-order correlation coefficient.RESULTS: 52.4% of the COPD patients were smokers compared to the healthy group (46.5%).
💡
Conclusion & Impact:We found an inverse correlation betweentriglyceride and functional residual capacity (p=-0.21, p=0.05) and a positive association between serum cholesterol and overall airwayresistance (R5) (p=0.24, p=0.04) and central airway resistance (R20) (p=0.32, p=0.004).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

OBJECTIVES: Although dietary patterns are known to modulate disease severity in patients with chronic obstructive pulmonary disease (COPD),the relationship between the circulating lipid profile and lung function in COPD has not been studied extensively.MATERIAL AND METHODS: There were 43 COPD patients with a history of smoking and 39 patients with a history of biomass fuel exposurerecruited in this study, along with 43 age-matched healthy controls. All participants underwent complete lung function profiling, and their glu-cose and lipid profiles were measured. The association between the metabolic profile and lung function was assessed using the Spearman’srank-order correlation coefficient.RESULTS: 52.4% of the COPD patients were smokers compared to the healthy group (46.5%). We found an inverse correlation betweentriglyceride and functional residual capacity (p=-0.21, p=0.05) and a positive association between serum cholesterol and overall airwayresistance (R5) (p=0.24, p=0.04) and central airway resistance (R20) (p=0.32, p=0.004). Low-density lipoprotein (LDL) cholesterol andhigh-density lipoprotein (HDL) ratio and LDL/HDL ratio were also found to correlate with R5 (p=0.25, 0.23, and 0.22, respectively) andR20 (p=0.31, 0.24, and 0.24, respectively). No significant association was observed between other metabolites and either spirometricor plethysmographic lung function indices.CONCLUSION: High serum triglyceride and cholesterol may increase the resistance in the airways, which may lead to increased airwayobstruction. Therefore, monitoring of lipid profile should be considered in the diagnosis and management of COPD.

🔖

Cite This Article

RAFIE, S., MOITRA, S., BRASHIER, B. B. (2018). Association between the Serum Metabolic Profile and Lung Function in Chronic Obstructive Pulmonary Disease. Turkish Thoracic Journal, Cilt: 19 - Sayı: 1, 13–18. https://ajindex.com/articles/418045

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Mannino DM, Buist AS. Global burden of COPD: risk fac- tors, prevalence, and future trends. Lancet 2007;370:765-73. [CrossRef] Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the di- agnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65. [CrossRef] Mathers CD, Loncar D. Projections of global mortality and bur- den of disease from 2002 to 2030. PLoS Med 2006;3:e442. [CrossRef] Gupta R, Bhadoria DP, Mittal A, et al. Lipid profile in obstructive airway disorders. J Assoc Physicians India 2002;50:186-7.
  2. Begum K, Begum MK, Sarker ZH, et al. Lipid profile status of chronic obstructive pulmonary disease in hospitalized patients. Bangladesh J Med Biochem 2010;3:42-5
  3. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Dis- ease (GOLD) 2017. Available from: http://goldcopd.org/. Date Last Accessed: March 5, 2017.
  4. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plas- ma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
  5. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38. [CrossRef] Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardiza- tion of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40. [CrossRef] Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommenda- tions and future developments. Eur Respir J 2003;22:1026-41. [CrossRef] Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-22. [CrossRef] Landbo C, Prescott E, Lange P, et al. Prognostic value of nu- tritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-61. [CrossRef] Fekete T, Mösler R. Plasma lipoproteins in chronic obstruc- tive pulmonary disease. Horm Metab Res 1987;19:661-2. [CrossRef] Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular dis- eases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-9. [CrossRef] MR N, K D, BK R. Lipoprotein profile in patien